Your prediction
Valbiotis Stock
Valbiotis dominated the market today, gaining €0.17 (4.370%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Valbiotis stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Valbiotis in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Valbiotis vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Valbiotis | 4.370% | - | - | - | - | - | - |
| Cerenis Therapeutics Holding S.A. | 1.480% | -0.208% | 1.374% | -40.948% | -22.159% | -10.206% | 195.077% |
| Sensorion SA | 0.600% | 2.736% | 0.297% | 159.501% | 69.000% | -70.155% | - |
| Genoway S.A. Inh. | -0.250% | 1.292% | -2.000% | 3.979% | -11.111% | 19.695% | 115.978% |
News
Valbiotis to launch its 100% natural dietary supplement for the management of hypercholesterolemia on the French market in May
Valbiotis to launch its 100% natural dietary supplement for the management of hypercholesterolemia on the French market in May
Valbiotis presents its 2024 financial communication calendar
Valbiotis presents its 2024 financial communication calendar